A multicenter observational study to evaluate the association between mineralocorticoid receptor antagonist and urine albumin-creatinine ratio at 6 months in heart failure patients with hypertension

A multicenter observational study to evaluate the association between mineralocorticoid receptor antagonist and urine albumin-creatinine ratio at 6 months in heart failure patients with hypertension - A multicenter observational study to evaluate the association between mineralocorticoid receptor antagonist and urine albumin-creatinine ratio at 6 months in heart failure patients with hypertension

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049598

Enrollment

200

Registered

2022-11-24

Start date

2022-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, heart failure, chronic kidney disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Hypertension 2. Heart failure requiring hospitalization 3. UACR>=30mg/gCr 4. K<5.1mEq/L

Exclusion criteria

Exclusion criteria: 1. MRA use at screening 2. eGFR<30 3. Acute coronary syndrome 4. Planned surgery within 6 months 5. Patients who cannot give their consent

Design outcomes

Primary

Measure	Time frame
Urine albumin-creatinine ratio at 6 months	—

Countries

Japan

Contacts

Public ContactKotaro Nochioka

Tohoku University Hospital Cardiovascular medicine

nochioka@cardio.med.tohoku.ac.jp0227177153

Outcome results